Market Tracker

06/27 8:53am ET

Seattle Genetics Inc (NASDAQ:SGEN)

37.59
Delayed Data
As of Jun 24
 -2.48 / -6.19%
Today’s Change
26.02
Today|||52-Week Range
52.33
-16.24%
Year-to-Date
No recent news for Seattle Genetics Inc.

Today’s Trading

Previous close40.07
Today’s open38.00
Day’s range37.50 - 39.43
Volume1,045,075
Average volume (3 months)1,038,229
Market cap$5.3B
Dividend yield--
Data as of 06/24/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-19.10%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+17.45%
P/E ratioNM
Price/Sales17.21
Price/Book7.65

Competitors

 Today’s
change
Today’s
% change
OPKOPKO Health Inc-0.29-2.97%
TAROTaro Pharmaceutical ...-4.56-3.18%
UTHRUnited Therapeutics ...-3.17-3.01%
----
Data as of 06/24/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$336.8M
Annual profit (last year)-$120.5M
Net profit margin-35.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts